FDA 522 Data Quality Remediation Calculator

Section 522 programs can slip when data quality cleanup is treated as background work. This calculator estimates remediation effort, timeline drag, and budget exposure from unresolved queries, missing fields, and re-adjudication cycles.

Interactive Calculator

Total patient records in scope

Records with missing critical fields (%)

Open data queries

Average remediation hours per issue

QA/DM blended labor rate ($/hour)

Weekly remediation team capacity (hours)

Run the calculator to estimate remediation workload and timeline impact.

Why Data Quality Is a 522 Schedule Risk

In many surveillance programs, enrollment appears on plan while evidence readiness is behind. That gap usually comes from data quality debt: unresolved queries, endpoint coding inconsistencies, and incomplete records that prevent timely analysis. The operational impact is delayed interim reviews, more rework cycles, and higher cost-to-confidence.

Data-quality remediation should be modeled as a first-class workstream. When teams ignore it in early planning, they overestimate available schedule buffer and underestimate provider support required for query closure and adjudication alignment.

This calculator provides a practical baseline so you can decide whether current team capacity is enough or whether provider scope needs reinforcement.

Remediation Tier Guidance

Controlled backlog: manageable debt if closure pace stays stable and governance is strict.

Elevated backlog: additional QA/DM support or stronger site coaching is usually needed.

Critical backlog: high probability of milestone slippage unless remediation is escalated immediately.

How to Reduce Remediation Burden

Segment queries by patient-safety and endpoint-criticality so teams clear high-value issues first.
Implement weekly closure SLAs by site, with root-cause tagging for recurring issues.
Predefine adjudication decision rules to avoid rework from interpretation drift.
Track closure velocity and reopen rates together; velocity alone can hide poor quality fixes.
Align provider incentives to closure quality, not only query count throughput.

These controls are small, but together they stabilize reporting readiness and protect budget from iterative cleanup cycles.

References

[1] FDA, Postmarket Surveillance Under Section 522: official overview
[2] eCFR, 21 CFR Part 822: regulatory text
[3] FDA, Device quality systems resources: quality systems information